14-104929990-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138790.5(PLD4):c.602G>A(p.Arg201Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000589 in 1,613,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000061 ( 0 hom. )
Consequence
PLD4
NM_138790.5 missense
NM_138790.5 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: 3.44
Genes affected
PLD4 (HGNC:23792): (phospholipase D family member 4) Predicted to enable single-stranded DNA 5'-3' exodeoxyribonuclease activity. Predicted to be involved in hematopoietic progenitor cell differentiation; phagocytosis; and regulation of cytokine production involved in inflammatory response. Predicted to be located in early endosome and endoplasmic reticulum membrane. Predicted to be active in several cellular components, including endoplasmic reticulum; phagocytic vesicle; and trans-Golgi network membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05413875).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLD4 | NM_138790.5 | c.602G>A | p.Arg201Gln | missense_variant | 6/11 | ENST00000392593.9 | NP_620145.2 | |
PLD4 | NM_001308174.2 | c.623G>A | p.Arg208Gln | missense_variant | 6/11 | NP_001295103.1 | ||
PLD4 | XM_011536411.3 | c.623G>A | p.Arg208Gln | missense_variant | 6/11 | XP_011534713.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLD4 | ENST00000392593.9 | c.602G>A | p.Arg201Gln | missense_variant | 6/11 | 1 | NM_138790.5 | ENSP00000376372.5 | ||
PLD4 | ENST00000540372.5 | c.623G>A | p.Arg208Gln | missense_variant | 6/11 | 2 | ENSP00000438677.1 | |||
PLD4 | ENST00000649344.1 | c.602G>A | p.Arg201Gln | missense_variant | 6/11 | ENSP00000497627.1 | ||||
PLD4 | ENST00000557573.1 | c.596G>A | p.Arg199Gln | missense_variant | 6/7 | 3 | ENSP00000451278.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000105 AC: 26AN: 248790Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135218
GnomAD3 exomes
AF:
AC:
26
AN:
248790
Hom.:
AF XY:
AC XY:
9
AN XY:
135218
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461228Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 726912
GnomAD4 exome
AF:
AC:
89
AN:
1461228
Hom.:
Cov.:
31
AF XY:
AC XY:
42
AN XY:
726912
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74476
GnomAD4 genome
AF:
AC:
6
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
10
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | The c.602G>A (p.R201Q) alteration is located in exon 6 (coding exon 5) of the PLD4 gene. This alteration results from a G to A substitution at nucleotide position 602, causing the arginine (R) at amino acid position 201 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
.;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;.;M;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;D;D
REVEL
Benign
Sift
Benign
.;D;D;D
Sift4G
Uncertain
.;D;D;D
Polyphen
0.97, 0.95
.;D;P;.
Vest4
0.39, 0.40
MutPred
0.57
.;Gain of catalytic residue at V207 (P = 0);.;.;
MVP
0.13
MPC
0.49
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at